![Jean-Michel Levy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Michel Levy
Director/Board Member at ILTOO Pharma SAS
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Pierre Marc Bélichard | M | 63 |
ILTOO Pharma SAS
![]() ILTOO Pharma SAS Miscellaneous Commercial ServicesCommercial Services ILTOO Pharma SAS is a French clinical-stage biotechnology company that focuses on developing therapies to re-educate the immune system and revolutionize the treatment of auto/neuro-immune diseases. The private company is based in Paris, France, and the CEO of the company is Jeff Lyons. The company's main focus is on amyotrophic lateral sclerosis (ALS) and systemic lupus erythematosus (SLE), which are progressive and life-threatening neuromuscular disorders affecting motor neurons in both the brain and spinal cord and a chronic systemic autoimmune disease that affects the joints, kidney, mucus membrane, and blood vessels, respectively. | - |
Antoine Barouky | M | - |
ILTOO Pharma SAS
![]() ILTOO Pharma SAS Miscellaneous Commercial ServicesCommercial Services ILTOO Pharma SAS is a French clinical-stage biotechnology company that focuses on developing therapies to re-educate the immune system and revolutionize the treatment of auto/neuro-immune diseases. The private company is based in Paris, France, and the CEO of the company is Jeff Lyons. The company's main focus is on amyotrophic lateral sclerosis (ALS) and systemic lupus erythematosus (SLE), which are progressive and life-threatening neuromuscular disorders affecting motor neurons in both the brain and spinal cord and a chronic systemic autoimmune disease that affects the joints, kidney, mucus membrane, and blood vessels, respectively. | - |
Jose Achache | M | - |
ILTOO Pharma SAS
![]() ILTOO Pharma SAS Miscellaneous Commercial ServicesCommercial Services ILTOO Pharma SAS is a French clinical-stage biotechnology company that focuses on developing therapies to re-educate the immune system and revolutionize the treatment of auto/neuro-immune diseases. The private company is based in Paris, France, and the CEO of the company is Jeff Lyons. The company's main focus is on amyotrophic lateral sclerosis (ALS) and systemic lupus erythematosus (SLE), which are progressive and life-threatening neuromuscular disorders affecting motor neurons in both the brain and spinal cord and a chronic systemic autoimmune disease that affects the joints, kidney, mucus membrane, and blood vessels, respectively. | - |
Jeff Lyons | M | - |
ILTOO Pharma SAS
![]() ILTOO Pharma SAS Miscellaneous Commercial ServicesCommercial Services ILTOO Pharma SAS is a French clinical-stage biotechnology company that focuses on developing therapies to re-educate the immune system and revolutionize the treatment of auto/neuro-immune diseases. The private company is based in Paris, France, and the CEO of the company is Jeff Lyons. The company's main focus is on amyotrophic lateral sclerosis (ALS) and systemic lupus erythematosus (SLE), which are progressive and life-threatening neuromuscular disorders affecting motor neurons in both the brain and spinal cord and a chronic systemic autoimmune disease that affects the joints, kidney, mucus membrane, and blood vessels, respectively. | - |
Jean Van Den Esch | M | - |
ILTOO Pharma SAS
![]() ILTOO Pharma SAS Miscellaneous Commercial ServicesCommercial Services ILTOO Pharma SAS is a French clinical-stage biotechnology company that focuses on developing therapies to re-educate the immune system and revolutionize the treatment of auto/neuro-immune diseases. The private company is based in Paris, France, and the CEO of the company is Jeff Lyons. The company's main focus is on amyotrophic lateral sclerosis (ALS) and systemic lupus erythematosus (SLE), which are progressive and life-threatening neuromuscular disorders affecting motor neurons in both the brain and spinal cord and a chronic systemic autoimmune disease that affects the joints, kidney, mucus membrane, and blood vessels, respectively. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jean-Luc Bélingard | M | 74 | 4 years | |
Maria Gabriella Camboni | M | 66 | - | |
Roberto Gradnik | M | 68 | 3 years | |
Louis Champion | M | 64 | 11 years | |
Charles Ruban | M | 52 | 9 years | |
Robert Zeldin | M | 61 | 4 years | |
Patrick J. Langlois | M | 78 | 4 years | |
Jacques Theurillat | M | 65 | - | |
Patrick Lee | M | 67 | - | |
Christophe Libert | M | - | - | |
Paola Ricci | F | 66 | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 16 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jean-Michel Levy
- Personal Network